RYK is one of the receptors for Wnt family member 5A (WNT5A) and has been reported to be involved in invasive activity in glioma-derived cells [73–75] and to facilitate the pro-apoptotic and anti-proliferative effects of WNT5A in prostate cancer cells [76]. Here, WNT5A is linked to central nervous system cancer.